The stock of Shockwave Medical Inc. (SWAV) has gone up by 13.18% for the week, with a 21.62% rise in the past month and a 64.44% rise in the past quarter. The volatility ratio for the week is 5.72%, and the volatility levels for the past 30 days are 3.55% for SWAV. The simple moving average for the last 20 days is 18.10% for SWAV’s stock, with a simple moving average of 39.00% for the last 200 days.
Is It Worth Investing in Shockwave Medical Inc. (NASDAQ: SWAV) Right Now?
Shockwave Medical Inc. (NASDAQ: SWAV) has a higher price-to-earnings ratio of 81.86x compared to its average ratio. SWAV has 36-month beta value of 0.90. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for SWAV is 36.62M, and currently, short sellers hold a 4.63% ratio of that float. The average trading volume of SWAV on March 27, 2024 was 516.20K shares.
SWAV) stock’s latest price update
The stock price of Shockwave Medical Inc. (NASDAQ: SWAV) has jumped by 10.04 compared to previous close of 287.23. Despite this, the company has seen a gain of 13.18% in its stock price over the last five trading days. Market Watch reported 2024-03-26 that Shares of medical-device maker Shockwave Medical Inc. rose Tuesday following a report that Johnson & Johnson was in talks to acquire the company.
Analysts’ Opinion of SWAV
Many brokerage firms have already submitted their reports for SWAV stocks, with UBS repeating the rating for SWAV by listing it as a “Neutral.” The predicted price for SWAV in the upcoming period, according to UBS is $218 based on the research report published on September 29, 2023 of the previous year 2023.
Morgan Stanley, on the other hand, stated in their research note that they expect to see SWAV reach a price target of $335, previously predicting the price at $291. The rating they have provided for SWAV stocks is “Overweight” according to the report published on July 10th, 2023.
Morgan Stanley gave a rating of “Equal-Weight” to SWAV, setting the target price at $291 in the report published on May 30th of the previous year.
SWAV Trading at 27.58% from the 50-Day Moving Average
After a stumble in the market that brought SWAV to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 0.04% of gains for the given period.
Volatility was left at 3.55%, however, over the last 30 days, the volatility rate increased by 5.72%, as shares surge +19.96% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +46.22% upper at present.
During the last 5 trading sessions, SWAV rose by +13.18%, which changed the moving average for the period of 200-days by +9.62% in comparison to the 20-day moving average, which settled at $270.26. In addition, Shockwave Medical Inc. saw 65.86% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SWAV starting from WATKINS FRANK T, who sale 2,000 shares at the price of $253.65 back on Mar 06 ’24. After this action, WATKINS FRANK T now owns 4,532 shares of Shockwave Medical Inc., valued at $507,294 using the latest closing price.
Phung Trinh, the VP, Finance of Shockwave Medical Inc., sale 21 shares at $253.14 during a trade that took place back on Mar 06 ’24, which means that Phung Trinh is holding 31,024 shares at $5,316 based on the most recent closing price.
Stock Fundamentals for SWAV
Current profitability levels for the company are sitting at:
- 0.22 for the present operating margin
- 0.87 for the gross margin
The net margin for Shockwave Medical Inc. stands at 0.2. The total capital return value is set at 0.11. Equity return is now at value 24.96, with 13.24 for asset returns.
Based on Shockwave Medical Inc. (SWAV), the company’s capital structure generated 0.52 points at debt to capital in total, while cash flow to debt ratio is standing at 0.27. The debt to equity ratio resting at 1.1. The interest coverage ratio of the stock is 23.23.
Currently, EBITDA for the company is 176.35 million with net debt to EBITDA at 2.59. When we switch over and look at the enterprise to sales, we see a ratio of 16.79. The receivables turnover for the company is 6.37for trailing twelve months and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 11.76.
Conclusion
To put it simply, Shockwave Medical Inc. (SWAV) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
